 | • レポートコード：MRC2304I0165 • 出版社/出版日：Persistence Market Research / 2023年1月6日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の乱用薬物検査サービス市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、市場背景、市場分析・予測、薬物別（アルコール、カンナビス/マリファナ、コカイン、オピオイド、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Quest Diagnostics, Inc.、Abbott Laboratories、Clinical Reference Laboratory, Inc.、Laboratory Corporation of America Holdings、Cordant Health Solutions、Legacy Medical Services, LLC.、DrugScan、Omega Laboratories, Inc.、Psychemedics Corporation、Mayo Clinic Laboratoriesなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・市場分析・予測 ・世界の乱用薬物検査サービス市場規模：薬物別 - アルコールの市場規模 - カンナビス/マリファナの市場規模 - コカインの市場規模 - オピオイドの市場規模 - その他薬物の市場規模 ・世界の乱用薬物検査サービス市場規模：地域別 - 北米の乱用薬物検査サービス市場規模 - 中南米の乱用薬物検査サービス市場規模 - ヨーロッパの乱用薬物検査サービス市場規模 - アジア太平洋の乱用薬物検査サービス市場規模 - 中東・アフリカの乱用薬物検査サービス市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Global Drug of Abuse Testing Services Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033
A recent market study published by Persistence Market Research on the Drug of Abuse Testing Services market offers global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Drug of Abuse Testing Services market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Drug Type
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Other Drug Types
By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the Drug of Abuse Testing Services market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Drug of Abuse Testing Services market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Drug of Abuse Testing Services market in this chapter, which will help them understand basic information about the Drug of Abuse Testing Services market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the Drug of Abuse Testing Services market report.
Chapter 03 – Market Background
The associated industry assessment of the global Drug of Abuse Testing Services market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Drug of Abuse Testing Services market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis, social media sentiment analysis, and consumer behavior analysis for the market. It offers provides key market dynamics of the Drug of Abuse Testing Services market, which include drivers, restraints, and opportunities.
Chapter 04 – Global Drug of Abuse Testing Services market Demand Analysis 2018-2022 and Forecast, 2023-2033
This section provides detailed analysis of the historical custom Drug of Abuse Testing Services market value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2022–2023) and an absolute opportunity for the forecast period (2023–2033).
Chapter 05 – Global Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033, by Drug type
Based on drug type, the Drug of Abuse Testing Services market is segmented in Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types. In this chapter, readers can find market attractiveness analysis, based on drug type.
Chapter 06 – Global Drug of Abuse Testing Services Market Analysis 2018-2022 and Opportunity Assessment 2023-2033 by region
This chapter explains how the Drug of Abuse Testing Services market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).
Chapter 07 – North America Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Drug of Abuse Testing Services market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth in the North America region.
Chapter 08 – Latin America Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug of Abuse Testing Services market in the Latin America region. This chapter also includes growth prospects of the Drug of Abuse Testing Services market in leading LATAM countries such as Brazil, Mexico, Argentina and Rest of Latin America.
Chapter 09 – Europe Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033
Important growth prospects of the Drug of Abuse Testing Services market in several countries such as Germany, Italy, France, U.K., Spain, Belgium and Rest of Europe are included in this chapter.
Chapter 10 –Asia Pacific Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Drug of Abuse Testing Services market in the Asia Pacific region, along with a country-wise assessment that includes, China, Japan, South Korea, India, Australia and rest of Asia Pacific. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.
Chapter 11 – Middle East and Africa Drug of Abuse Testing Services market Analysis 2018-2022 and Forecast 2023-2033
This chapter offers insights into how the Drug of Abuse Testing Services market is expected to grow in major countries in the MEA region such as South Africa, Saudi Arabia, UAE and Rest of MEA, during the forecast period 2023-2033.
Chapter 12 – Key Countries Drug of Abuse Testing Services market Analysis
This chapter offers insights into how the Drug of Abuse Testing Services market is expected to grow in key countries such as U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, Belgium, China, Japan, South Korea, India, Australia, Saudi Arabia, South Africa, U.A.E. during the forecast period 2023-2033.
Chapter 13 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the Drug of Abuse Testing Services market along with their market presence analysis by region and product portfolio.
Chapter 14 – Competition Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in Drug of Abuse Testing Services market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Quest Diagnostics, Abbott Laboratories, Cordant Health Solutions, Omega Laboratories, and Mayo Clinic Laboratories, among others.
Chapter 15 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Drug of Abuse Testing Services market report.
Chapter 16 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the Drug of Abuse Testing Services market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2018-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2023-2033
5.3.1. Alcohol
5.3.2. Cannabis/Marijuana
5.3.3. Cocaine
5.3.4. Opioids
5.3.5. Amphetamine & Methamphetamine
5.3.6. LSD
5.3.7. Other Drug Types
5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2018-2022
5.5. Absolute $ Opportunity Analysis By Drug Type, 2023-2033
6. Global Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Drug Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Drug Type
7.4. Key Takeaways
8. Latin America Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Drug Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Drug Type
8.4. Key Takeaways
9. Europe Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Drug Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Drug Type
9.4. Key Takeaways
10. Asia Pacific Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Drug Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Drug Type
10.4. Key Takeaways
11. Middle East and Africa Drug of Abuse Testing Services Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Drug Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Drug Type
11.4. Key Takeaways
12. Key Countries Drug of Abuse Testing Services Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Drug Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Drug Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Drug Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Drug Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Drug Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Drug Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Drug Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Drug Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Drug Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Drug Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Drug Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Drug Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Drug Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Drug Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Drug Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Drug Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Drug Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Drug Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Drug Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Drug Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Quest Diagnostics, Inc.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Abbott Laboratories
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Clinical Reference Laboratory, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Laboratory Corporation of America Holdings
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Cordant Health Solutions
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Legacy Medical Services, LLC.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. DrugScan
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Omega Laboratories, Inc.
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Psychemedics Corporation
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Mayo Clinic Laboratories
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology